BirchBioMed Receives Health Canada Approval for Topical Cream (NPN 80147114)

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

BirchBioMed-Health

More Like This

Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study

UPM Biomedicals launches FibGel™ the world's first injectable nanocellulose hydrogel for medical devices

ACCESSWIRE associated0

GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis

Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)

PR Newswire associated0

First Breakthrough Study Highlights Superiority of MatriDerm® in Wound Healing

PR Newswire associated0

European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union

PR Newswire associated0

Alphyn Receives Notice of Claims Allowance for U.S. Patent Covering Zabalafin Hydrogel

SciBase receives approval by FDA for extended labelling in the US